A Multicenter, Two-Part, Phase 1B Clinical Study Of CMP-001 In Combination With Atezolizumab With And Without Radiation Therapy In Subjects With Advanced Non Small Cell Lung Cancer (NSCLC)
Phase of Trial: Phase I
Latest Information Update: 27 Jun 2018
At a glance
- Drugs Atezolizumab (Primary) ; CMP 001 (Primary) ; CMP 001 (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- Sponsors Checkmate Pharmaceuticals
- 24 Apr 2018 According to the Checkmate Pharmaceuticals media release, company has initiated the treatment in this trial.
- 20 Apr 2018 Status changed from not yet recruiting to recruiting.
- 22 Feb 2018 New trial record